Dissecting the mechanisms of the PD‐L1‐driven tumorigenesis of NF2‐associated meningioma will help to improve our understanding of the mechanisms underlying tumor progression and could facilitate the further refinement of current therapies to improve the treatment of NF2 patients. This evidence concerns the gene CD274 and meningioma.